(Q46961856)

English

Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

Darío Acuña-Castroviejo

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

author name string

Daniel Alvira

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

Marta Tajes

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

Ester Verdaguer

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

40

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

251-258

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

Pathogenesis of nigral cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Mitochondrial involvement in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Mitochondria and degenerative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

A possible stimulatory effect of FMRFamide on neural nitric oxide production in the central nervous system of Helix lucorum L.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Apoptotic molecules and MPTP-induced cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Cdk5: mediator of neuronal death and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin mitigates mitochondrial malfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Melatonin attenuates 1-methyl-4-phenylpyridinium-induced PC12 cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Regulation of antioxidant enzymes: a significant role for melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

A decade of CDK5.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Neurotoxicity induces cleavage of p35 to p25 by calpain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Amplification of dopaminergic signaling by a positive feedback loop

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2005.00308.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2005.00308.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16499562

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46961856&oldid=2139751335"